Enoxaparin Sales Data

Rank 37 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows enoxaparin U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 37 (1) 6.55% 15.55%
Q3 2013 38 (5) -12.31% -10.90%
Q2 2013 33 (3) 0.02% -0.37%
Q1 2013 36 (5) -7.37% -0.90%
Q4 2012 31 (1) 1.54% 16.37%
Q3 2012 30 (3) -15.96% -2.35%
Q2 2012 27 (3) 4.44% 9.75%
Q1 2012 30 (4) -8.30% 0.55%
Q4 2011 26 (12) 36.13% 118.86%
Q3 2011 38 (1) 5.21% 4.41%
Q2 2011 39 (8) 8.08% 10.80%
Q1 2011 47

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web4)